Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
Metadata
- PMID: 36302761
- Authors: Ravindranathan S, Passang T, Li JM, Wang S, Dhamsania R et al.
- Journal: Nat Commun
- Year: 2022
Related Peptides
Key Findings
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
Tags
#research #pubmed #vip